Availability of oxygen plays an important role in tissue organization and cell-type specific metabolism. It is, however, difficult to analyze hypoxia-related adaptations in vitro because of inherent limitations of experimental model systems. In this study, we establish a microfluidic tissue culture protocol to generate hypoxic gradients in vitro, mimicking the conditions found in the liver acinus. To accomplish this, four microfluidic chips, each containing two chambers, were serially connected to obtain eight interconnected chambers. HepG2 hepatocytes were uniformly seeded in each chamber and cultivated under a constant media flow of 50 µL/h for 72 h. HepG2 oxygen consumption under flowing media conditions established a normoxia to hypoxia gradient within the chambers, which was confirmed by oxygen sensors located at the inlet and outlet of the connected microfluidic chips. Expression of Hif1α mRNA and protein was used to indicate hypoxic conditions in the cells and albumin mRNA and protein expression served as a marker for liver acinus-like zonation. Oxygen measurements performed over 72 h showed a change from 17.5% to 15.9% of atmospheric oxygen, which corresponded with a 9.2% oxygen reduction in the medium between chamber1 (inlet) and 8 (outlet) in the connected microfluidic chips after 72 h. Analysis of Hif1α expression and nuclear translocation in HepG2 cells additionally confirmed the hypoxic gradient from chamber1 to chamber8. Moreover, albumin mRNA and protein levels were significantly reduced from chamber1 to chamber8, indicating liver acinus zonation along the oxygen gradient. Taken together, microfluidic cultivation in interconnected chambers provides a new model for analyzing cells in a normoxic to hypoxic gradient in vitro. By using a well-characterized cancer cell line as a homogenous hepatocyte population, we also demonstrate that an approximate 10% reduction in oxygen triggers translocation of Hif1α to the nucleus and reduces albumin production.
Objective. This work investigates the use of Al 2 O 3 :C and Al 2 O 3 :C,Mg optically stimulated luminescence (OSL) detectors to determine both the dose and the radiation quality in light ion beams. The radiation quality is here expressed through either the linear energy transfer (LET) or the closely related metric Qeff , which depends on the particle’s speed and effective charge. The derived LET and Qeff values are applied to improve the dosimetry in light ion beams. Approach. OSL detectors were irradiated in mono-energetic 1 H-, 4 He-, 12 C-, and 16 O-ion beams. The OSL signal is associated with two emission bands that were separated using a pulsed stimulation technique and subjected to automatic corrections based on reference irradiations. Each emission band was investigated independently for dosimetry, and the ratio of the two emission intensities was parameterized as a function of fluence- and dose-averaged LET, as well as Qeff . The determined radiation quality was subsequently applied to correct the dose for ionization quenching. Main results. For both materials, the Qeff determinations in 1 H- and 4 He-ion beams are within 5 % of the Monte Carlo simulated values. Using the determined radiation quality metrics to correct the nonlinear (ionization quenched) detector response leads to doses within 2 % of the reference doses. Significance. Al 2 O 3 :C and Al 2 O 3 :C,Mg OSL detectors are applicable for dosimetry and radiation quality estimations in 1 H- and 4 He-ions. Only Al 2 O 3 :C,Mg shows promising results for dosimetry in 12 C-ions. Across both materials and the investigated ions, the estimated Qeff values were less sensitive to the ion types than the estimated LET values were. The reduced uncertainties suggest new possibilities for simultaneously estimating the physical and biological dose in particle therapy with OSL detectors.
Objective . Carbon ion radiotherapy is a promising radiation technique for malignancies like pancreatic cancer. However, organs’ motion imposes challenges for achieving homogeneous dose delivery. In this study, an anthropomorphic P ancreas P hantom for I on-b e am T herapy (PPIeT) was developed to simulate breathing and gastrointestinal motion during radiotherapy. Approach . The developed phantom contains a pancreas, two kidneys, a duodenum, a spine and a spinal cord. The shell of the organs was 3D printed and filled with agarose-based mixtures. Hounsfield Units (HU) of PPIeTs’ organs were measured by CT. The pancreas motion amplitude in cranial-caudal (CC) direction was evaluated from patients’ 4D CT data. Motions within the obtained range were simulated and analyzed in PPIeT using MRI. Additionally, GI motion was mimicked by changing the volume of the duodenum and quantified by MRI. A patient-like treatment plan was calculated for carbon ions, and the phantom was irradiated in a static and moving condition. Dose measurements in the organs were performed using an ionization chamber and dosimetric films. Main results . PPIeT presented tissue equivalent HU and reproducible breathing-induced CC displacements of the pancreas between (3.98 ± 0.36) mm and a maximum of (18.19 ± 0.44) mm. The observed maximum change in distance of (14.28 ± 0.12) mm between pancreas and duodenum was consistent with findings in patients. Carbon ion irradiation revealed homogenous coverage of the virtual tumor at the pancreas in static condition with a 1% deviation from the treatment plan. Instead, the dose delivery during motion with the maximum amplitude yielded an underdosage of 21% at the target and an increased uncertainty by two orders of magnitude. Significance . A dedicated phantom was designed and developed for breathing motion assessment of dose deposition during carbon ion radiotherapy. PPIeT is a unique tool for dose verification in the pancreas and its organs at risk during end-to-end tests.
Background: In hadron therapy, out‐of‐field doses, which may in the long‐term cause secondary cancers, are mostly due to neutrons. Very recently, 4 He and 16 O beams have been added to protons and 12 C ions for clinical therapy. Purpose: The focus of this article is to compare secondary neutron doses produced by clinical protons, 4 He, 12 C, and 16 O ion beams. Methods: Ambient dose equivalent, H *(10), measurements were performed, with five types of rem counters, of the neutron field produced by the four primary ions impinging on a water phantom. This experiment was performed at the Heidelberg Ion Beam Therapy Center (HIT) in the framework of the activities of the European Radiation Dosimetry Group (EURADOS). The experimental data are normalized to both unit primary particle and target dose, and are further compared to Monte Carlo (MC) simulations performed with the FLUKA and MCNP codes. Results: The intensity of the neutron field increases with ion mass, and the trend is more significant in the forward direction. The minimum H *(10) for all ions, 5µSv/Gy to 10µSv/Gy, was measured in the transverse and backward directions, whereas the maximum measured value was about 1.3 mSv/Gy for primary 16 O ions in the forward direction. Additional MC simulations are presented for a more detailed analysis of the rem counters’ response in the presence of heavy charged fragments. In the downstream direction, for 12 C and 16 O ions, approximately only 30% of the instruments’ counts are due to neutrons. Conclusion: The four extended‐range instruments provide reliable and consistent results, whereas the conventional rem counter underestimates H *(10) in a neutron field with a large high‐energy component. FLUKA and MCNP provide consistent predictions, within a factor of 1.6 for the downstream position and lower differences in the other cases, and are in agreement with the experimental data. It was found that under certain conditions neutrons do not represent the only secondary radiation field to be monitored; the presence of charged particles affects the performance of moderator‐type neutron detectors.